Theodor Leber
Theodor Leber (29 February 1840 – 17 April 1917) was a German ophthalmologist known for his contributions to the field of ophthalmology. He is best known for his research on various eye diseases, including Leber's congenital amaurosis and Leber's hereditary optic neuropathy.
Early Life and Education[edit | edit source]
Theodor Leber was born in Karlsruhe, Grand Duchy of Baden. He studied medicine at the University of Heidelberg, where he was influenced by the work of Hermann von Helmholtz. Leber completed his medical degree in 1862 and subsequently worked as an assistant to Albrecht von Graefe in Berlin.
Career[edit | edit source]
Leber's career was marked by significant contributions to the understanding of eye diseases. He held various academic positions, including a professorship at the University of Göttingen. His research primarily focused on the pathology of the eye, and he made groundbreaking discoveries in the field.
Leber's Congenital Amaurosis[edit | edit source]
Leber's congenital amaurosis (LCA) is a rare genetic eye disorder that leads to severe vision loss at birth. Leber was the first to describe this condition, which is now known to be caused by mutations in several different genes.
Leber's Hereditary Optic Neuropathy[edit | edit source]
Leber's hereditary optic neuropathy (LHON) is another condition named after Theodor Leber. It is a mitochondrial genetic disorder that leads to the degeneration of retinal ganglion cells and subsequent loss of central vision.
Legacy[edit | edit source]
Theodor Leber's work has had a lasting impact on the field of ophthalmology. His research laid the foundation for further studies on genetic eye diseases and their treatments. Leber's name continues to be associated with the conditions he first described, and his contributions are still recognized in modern medical literature.
Related Pages[edit | edit source]
- Ophthalmology
- Leber's congenital amaurosis
- Leber's hereditary optic neuropathy
- Hermann von Helmholtz
- Albrecht von Graefe
- University of Heidelberg
- University of Göttingen
References[edit | edit source]
External Links[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD